Beta-blocker drugs may slow Huntington’s disease progression

Post author:
Post published:December 2, 2024
Post category:uncategorized

A common heart drug may slow the progression of Huntington’s disease (HD), according to a new study by University of Iowa Health Care researchers.

Empowering individuals with knowledge, fostering healthier lifestyles, and fostering a community dedicated to diabetes awareness and prevention. Together, we’re shaping a healthier future.

Helpful Links

Subscribe To Us

By submitting via this part of the website you are granting us permission to store and process your data according to our Standard privacy policy

UPCOMING EVENTS

You Might Also Like

CheekAge: Next-gen epigenetic clock accurately predicts mortality risk

URI study explores consumer perceptions and nutrition of processed foods

Active ventilation can reduce bioaerosol risks in public restrooms

Helpful Links

Subscribe To Us